PROGNOSTIC IMPORTANCE OF HISTOLOGICAL CRITERIA OF MALIGNANT MELANOMAS

[1] ALLEN AC, 1953, CANCER-AM CANCER SOC, V6, P1, DOI 10.1002/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO

[2] 2-C

[3] ANDRADE R, 1966, B SOC FRANC DERM SYP, V73, P647

[4] BOLGERT M, 1966, B SOC FRANC DERM SYP, V73, P666

[5] BUREAU Y, 1966, B SOC FRANC DERM SYP, V73, P772

[6] DELACRETAZ J, 1960, DERMATOL VENEROL, V4, P591

[7] DUPERRAT B, 1966, B SOC FRANC DERM SYP, V73, P563

[8] GOTTRON VHA, 1960, DERMATOLOGIE VENE ED, V4, P591

[9] Graetz H, 1967, Z Haut Geschlechtskr, V42, P369

[10] JADDASSOHN J, 1933, HANDBUCH HAUT GES ED, V12, P1005

[1] ALLEN AC, 1953, CANCER-AM CANCER SOC, V6, P1, DOI 10.1002/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO

[2] 2-C

[3] ANDRADE R, 1966, B SOC FRANC DERM SYP, V73, P647

[4] BOLGERT M, 1966, B SOC FRANC DERM SYP, V73, P666

[5] BUREAU Y, 1966, B SOC FRANC DERM SYP, V73, P772

[6] DELACRETAZ J, 1960, DERMATOL VENEROL, V4, P591

[7] DUPERRAT B, 1966, B SOC FRANC DERM SYP, V73, P563

[8] GOTTRON VHA, 1960, DERMATOLOGIE VENE ED, V4, P591

[9] Graetz H, 1967, Z Haut Geschlechtskr, V42, P369

[10] JADDASSOHN J, 1933, HANDBUCH HAUT GES ED, V12, P1005